Submission Details
Molecule(s):
CC(=O)NCCc1c[nH]c2ccc(Cl)cc12
CC(=O)NCCc1c[nH]c2ccccc12
CC(=O)NCCc1cn(C)c2ccc(F)cc12
CC(=O)OCCc1c[nH]c2ccc(F)cc12
CC(=O)NCCc1c(O)[nH]c2ccc(F)cc12
Cn1c(O)c(ONC(N)=S)c2ccccc21
Cn1c(O)c(/N=N/C(N)=O)c2ccccc21
Cn1c(O)c(NOC(N)=S)c2ccccc21
Cn1c(O)c(NCC(N)=O)c2ccccc21
Cn1c(O)c(CNC(N)=O)c2ccccc21
Cn1c(O)c(/C=C/C(N)=O)c2ccccc21
Cn1c(O)c(CCC(N)=O)c2ccccc21
Design Rationale:
Variation of Z1220452176 Reference: n silicostudies on therapeutic agents for COVID-19: Drug repurposingapproach; Life Sciences, Volume 252, 1 July 2020, 117652